Imaging services firm Diagnostic Health Services of Dallas has engaged Prudential Securities to help the company explore “various alternatives to maximize DHS shareholder value.” The company did not specify what those alternatives might be, but
Imaging services firm Diagnostic Health Services of Dallas has engaged Prudential Securities to help the company explore various alternatives to maximize DHS shareholder value. The company did not specify what those alternatives might be, but they could include either acquisitions or a merger with another firm.
Any acquisitions could be complicated by the recent decline in Diagnostic Healths share price, however. The plunge of the stock market has cut the value of the companys stock in half, with DHS shares falling from around $10 a share in July to about $4.50 in mid-September. Shares of the firm were trading as high as $13 a share in late March. The lower value of DHS shares would make it more difficult to use stock as an acquisition vehicle.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.